¼¼°èÀÇ ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Medical Purity Analyzer Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1565726
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 316 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,482,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,413,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,792,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¼¼°è ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 590¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 5.90% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - ½ÃÀå ¿ªÇÐ

¹ÙÀÌ¿ÀÀǾàǰÀÇ ¼ö¿ä È®´ë¿Í ǰÁú °ü¸®ÀÇ Á߿伺ÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»ó

¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ßÀÇ ¼ºÀåÀ¸·Î º¹ÀâÇÑ »ý¹°ÇÐÀû Á¦Á¦ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇÑ °íµµÀÇ ¼øµµ ºÐ¼®¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϸ鼭 ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇϰí ÀÖÀ¸¸ç, FDA ¹× EMA¿Í °°Àº ±â°üÀÇ ±ÔÁ¦ ¹× ǰÁú ±âÁØ °­È­·Î ÀÎÇØ ÀǾàǰ ¼øµµ¿¡ ´ëÇÑ ¾ö°ÝÇÑ °Ë»ç°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÀǾàǰ ¿À¿° »ç°í·Î ÀÎÇÑ ºÒ¼ø¹° °ËÃâÀÇ Çʿ伺µµ ¼øµµ ºÐ¼®±â ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, Å©·Î¸¶Åä±×·¡ÇÇ ¹× ºÐ±¤¹ý °³¼±°ú °°Àº ºÐ¼® ±â¼úÀÇ Çõ½ÅÀ¸·Î ¼øµµ ºÐ¼®ÀÇ Á¤È®¼º°ú È¿À²¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å¾à ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó Á¦Ç° ¼ö¸íÁÖ±â Àü¹Ý¿¡ °ÉÃÄ ¼øµµ ºÐ¼®ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ´ÜŬ·ÐÇ×ü³ª ¹é½Å°ú °°Àº »ý¹°ÇÐÀû Á¦Á¦ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇÑ ¼øµµ ºÐ¼®Àº ºÐ¼® Àåºñ°¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀǾàǰÀÇ ¾ÈÁ¤¼º°ú À¯Åë±âÇÑÀ» Æò°¡Çϱâ À§ÇØ ÀǾàǰÀÇ ¼øµµ¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÏ´Â °Íµµ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡À¸·Î ÀÎÇØ ÀÇ·á¿ë ¼øµµ ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¿¬Æò±Õ ¾à 5.90%ÀÇ CAGR·Î ¸Å³â ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

À¯Çüº°·Î´Â ·¹ÀÌÀú ºÐ¼®±â ºÎ¹®ÀÌ ¼øµµ °ËÃâ¿¡ ÀÖ¾î ÷´Ü ±â¼ú Ȱ¿ëÀ¸·Î ÀÎÇØ 2023³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÆ½À´Ï´Ù.

¿ëµµº°·Î´Â ÀÇ·á¿ë °¡½º Á¦Á¶ ºÎ¹®ÀÌ 2023³â ÁÖ¿ä ¿ëµµ¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ´Â °¡½º Á¦Á¶ ÇöÀåÀÇ ¾ÈÀü¼ºÀ» À§ÇØ ÀÇ·á¿ë ¼øµµ ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô±â ¶§¹®ÀÔ´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â 2023³â Á¦¾àȸ»ç ºÎ¹®ÀÌ ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ ºÎ¹®À¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀÌ µÇ¾ú´Âµ¥, ÀÌ´Â »óÀ§ Á¦¾à»çÀÇ Á¸Àç¿Í ¹«¿ª ¼öÃâÀÌ ¿ëÀÌÇϱ⠶§¹®ÀÎ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù.

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®:

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ¼¼°è ½ÃÀåÀº À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

½ÃÀå À¯Çüº°·Î´Â ·¹ÀÌÀú ºÐ¼®±â, Àû¿Ü¼± ºÐ¼®±â, Áö¸£ÄÚ´Ï¾Æ ºÐ¼®±â, »óÀڱ⠺м®±â, ¿­Àüµµµµ ºÐ¼®±â, °¡½º Å©·Î¸¶Åä±×·¡ÇÇ ºÐ¼®±â, ±âŸ 7°¡Áö·Î ºÐ·ùµÇ¸ç, ·¹ÀÌÀú ºÐ¼®±â°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. »õ·Î¿î Ä¡·á¹ý°ú ½Å¾à¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀåÀº ¿ëµµº°·Î ÀÇ·á¿ë °¡½º Á¦Á¶, ÀÇ·á¿ë °¡½º °ËÁõ, ±âŸ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. ÀÇ·á¿ë °¡½º Á¦Á¶ ºÎ¹®ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á¿ë ¼øµµ ºÐ¼®±â¸¦ »ç¿ëÇϸé ǰÁú °ü¸® ¹× ¾ÈÀü Á¶Ä¡¿Í °°Àº ¸î °¡Áö Á¶Ä¡¸¦ ÃëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó Á¦¾àȸ»ç, º´¿ø, Çмú ¿¬±¸, ±âŸ µî 4°¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦¾àȸ»ç´Â ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÓ»ó½ÃÇè, ±ÔÁ¦ ´ç±¹ ½Åû, ÀÇ·á ÀÀ¿ë ºÐ¾ßÀÇ ¼ö¿ä Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¸¹Àº ¼öÀÇ ÀÇ·á ½Ã¼³, ¾ö°ÝÇÑ ±ÔÁ¦ Áöħ, ¼±ÁøÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó·Î ÀÎÇØ Áß¿äÇÑ ½ÃÀåÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Àß È®¸³µÈ ÀÇ·á ½Ã½ºÅÛ°ú ¾ö°ÝÇÑ ±ÔÁ¦°¡ ÀÖ´Â À¯·´Àº ¼¼°è ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·áºñ ÁöÃâ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó Çö´ëÈ­, ȯÀÚ ¾ÈÀü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù.

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - °æÀï »óȲ:

ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀåÀº ÀÇ·á ÇöÀå¿¡¼­ »ç¿ëµÇ´Â ÀÇ·á¿ë °¡½ºÀÇ ¾ÈÀü¼º, ±ÔÁ¤ Áؼö ¹× À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇÑ Ã·´Ü ±â¼úÀÇ Çʿ伺À¸·Î ÀÎÇØ °æÀïÀÌ Ä¡¿­ÇØÁö°í ÀÖ½À´Ï´Ù. °¢ ¾÷üµéÀº ÀÚµ¿È­, AI, IoT¸¦ ÀÇ·á¿ë ¼øµµ ºÐ¼®±â¿¡ ÅëÇÕÇÏ¿© Á¤È®¼º, È¿À²¼º, »ç¿ë ÆíÀǼºÀ» Çâ»ó½Ã۱â À§ÇØ ¿¬±¸ °³¹ß(R&D)¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ÈÞ´ë¿ë ºÐ¼®±â, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× µ¥ÀÌÅÍ ºÐ¼®À» Á¦°øÇÏ´Â ÀåÄ¡¿Í °°Àº Á¦Ç°¿¡¼­ º¼ ¼ö ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â FDA ¹× ISO Ç¥ÁØÀ» ÁؼöÇÏ´Â ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖÀ¸¸ç, °¡½º ¼øµµ ¼öÁØÀÌ È¯ÀÚ Ä¡·áÀÇ ¾ÈÀü °¡À̵å¶óÀÎÀ» ÁؼöÇϵµ·Ï º¸ÀåÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â ƯÁ¤ °í°´ÀÇ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ¾÷üµéÀÌ ´Ã¾î³ª°í ÀÖ½À´Ï´Ù.

2023³â 4¿ù, ÅÚ·¹´ÙÀÎÀº LDAR Àü¹®°¡µéÀÇ °¡½º ¹èÃâ °ü¸®¿¡ µµ¿òÀÌ µÇ´Â G ½Ã¸®Áî ±¤ÇÐ °¡½º À̹Ì¡ Ä«¸Þ¶ó¸¦ ¹ßÇ¥Çß½À´Ï´Ù.

2022³â 12¿ù, ¿¡¸Ó½¼ ÀÏ·ºÆ®¸¯Àº Cross by J ½Ã¸®Áî ¾Ð·Â ¸±¸®ÇÁ ¹ëºê(PRV)¸¦ Á¦Ç° ¶óÀο¡ µµÀÔÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±âÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â »ê¾÷ Á¶»ç

Á¦5Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå »óȲ

Á¦7Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - À¯Çüº°

Á¦8Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - ¿ëµµº°

Á¦9Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀÇ·á¿ë ¼øµµ ºÐ¼®±â ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Medical Purity Analyzer Market size was valued at USD 405.90 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

A Medical Purity Analyzer is a device or system used to assess the purity of pharmaceutical products, medical compounds, or biological samples. It typically employs various analytical techniques, such as chromatography, spectroscopy, or mass spectrometry, to measure the concentration of active ingredients and detect impurities or contaminants.

Medical Purity Analyzer Market- Market Dynamics

Growing demand from biopharmaceuticals and emphasis on quality control is expected to propel market demand

The growth of the biopharmaceutical sector increases the need for advanced purity analysis to ensure the safety and efficacy of complex biologics, boosting medical purity analyzer market growth. Increasing regulations and quality standards from organizations like the FDA and EMA necessitate rigorous testing for pharmaceutical purity. Also, the need to detect impurities due to incidents of contamination in pharmaceuticals drives the demand for purity analyzers.

Furthermore, innovations in analytical technologies, such as improved chromatography and spectroscopy techniques, enhance the accuracy and efficiency of purity analysis. Moreover, increased investment in research and development for new drugs fuels the need for purity analysis throughout the product lifecycle. Analyzing the purity of biologics, such as monoclonal antibodies and vaccines, to guarantee their safety and efficacy analyzers are widely utilized. Monitoring the purity of pharmaceuticals over time to assess their stability and shelf life is necessary. All these benefits are boosting the demand for medical purity analyzers.

Medical Purity Analyzer Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on Type segmentation, the laser analyzer segment was predicted to show maximum market share in the year 2023, owing to advanced tech utilization in purity detection.

Based on Application segmentation, medical gas production segment was the leading Application in 2023, owing to high demand for medical purity analyzer in gas production sites for safety.

Based on End User segmentation, pharmaceutical companies' segment was the leading End User segment in 2023, due to increasing need for purity analysis of different APIs.

On the basis of region, Asia Pacific was the leading revenue generator in 2023, due to the presence of top pharma companies and easy trade exports.

Medical Purity Analyzer Market- Segmentation Analysis:

The Global Medical Purity Analyzer Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into seven categories based on Type: laser analyzer, infrared analyzer, zirconia analyzer, paramagnetic analyzer, thermal conductivity analyzer, gas chromatography analyzer, and others. The laser analyzer segment dominates the market. Increasing demand from new therapies and drugs is expected to fuel segment growth.

The market is divided into four categories based on Application: medical gas production, medical gas verification, and others. The medical gas production segment dominates the market. Several measures like quality control & safety measures can be tapped in using medical purity analyzer.

The market is divided into four categories based on End User: pharmaceutical companies, hospitals, academic research, and others. The pharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing demand from clinical trials, regulatory submission and medical applications are thriving segment growth.

Medical Purity Analyzer Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is a significant player due to the high number of healthcare facilities, stringent regulatory guidelines, and advanced healthcare infrastructure. Europe, with its established healthcare system and stringent regulations, plays a vital role in the global Medical Purity Analyzer market. The Asia Pacific region shows significant growth due to increasing healthcare expenditures, modernization of medical infrastructure, and rising awareness of patient safety.

Medical Purity Analyzer Market- Competitive Landscape:

The Medical Purity Analyzer market is highly competitive, driven by the need for advanced technology to ensure the safety, compliance, and effectiveness of medical gases used in healthcare settings. Companies are investing heavily in research and development (R&D) to integrate automation, AI, and IoT into medical purity analyzers, improving accuracy, efficiency, and ease of use. This trend is seen in products like portable analyzers and devices that offer real-time monitoring and data analytics. Companies are focusing on developing solutions that align with FDA, ISO standards, ensuring gas purity levels meet safety guidelines for patient care. Companies are increasingly offering customized solutions to meet specific client needs, especially in emerging markets.

In April 2023, Teledyne introduced G series optical gas imaging cameras that help LDAR professionals in managing gas emissions.

In December 2022, Emerson Electric Co., introduced Cross by J series Pressure relief Valve (PRV) into their product line.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MEDICAL PURITY ANALYZER MARKET KEY PLAYERS

GLOBAL MEDICAL PURITY ANALYZER MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

GLOBAL MEDICAL PURITY ANALYZER MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL MEDICAL PURITY ANALYZER MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

GLOBAL MEDICAL PURITY ANALYZER MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. Medical Purity Analyzer Market Overview

2. Executive Summary

3. Medical Purity Analyzer Key Market Trends

4. Medical Purity Analyzer Industry Study

5. Medical Purity Analyzer Market: COVID-19 Impact Analysis

6. Medical Purity Analyzer Market Landscape

7. Medical Purity Analyzer Market - By Type

8. Medical Purity Analyzer Market - By Application

9. Medical Purity Analyzer Market - By End User

10. Medical Purity Analyzer Market- By Geography

11. Key Vendor Analysis- Medical Purity Analyzer Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â